BioCurity Pharmaceuticals

BioCurity Pharmaceuticals

Growth Stage

Because fighting cancer is hard enough!

Because fighting cancer is hard enough!

Overview

Raised this Round: Raised: $403,066

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/16/2019

Close Date

06/29/2020

Min. Goal
$9,996
Max. Goal
$1,069,997
Min. Investment

$1,003

Security Type

Equity - Preferred

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$4.25

Pre-Money Valuation

$34,019,537

Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Location

Jupiter, Florida

Business Type

High Growth

BioCurity Pharmaceuticals is raising funds on StartEngine via Equity with a $34 million valuation cap. The team is in the clinical stages of creating technology to minimize skin damage during a cancer patient's radiation therapy. The drug mitigates tissue damage during this therapy and has already been preclinically tested for multiple cancer types. The team aims to be the first FDA approved drug used to prevent radiation dermatitis. The minimum investment amount for BioCurity Pharmaceuticals is $1003 and the minimum target for the round is $9996.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,059,818

$-2,844,968

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$167,281

$203,307

Accounts Receivable

$0

$0

Total Assets

$342,484

$409,874

Short-Term Debt

$2,121,930

$1,320,617

Long-Term Debt

$0

$0

Total Liabilities

$2,121,930

$1,320,617

Financials as of: 12/16/2019
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
BioCurity Pharmaceuticals 04/29/2021 StartEngine $36,320,126 $238,442 Equity - Preferred Funded RegCF
BioCurity Pharmaceuticals 06/28/2020 StartEngine $34,019,537 $403,066 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
BioCurity Pharmaceuticals on StartEngine
Platform: StartEngine
Security Type: Equity - Preferred
Valuation: $34,019,537
Price per Share: $4.25

Follow company

Follow BioCurity Pharmaceuticals on StartEngine

Buy BioCurity Pharmaceuticals's Deal Report

Warning: according to the close date for this deal, BioCurity Pharmaceuticals may no longer be accepting investments.

BioCurity Pharmaceuticals Deal Report

Get KingsCrowd’s comprehensive report on BioCurity Pharmaceuticals including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether BioCurity Pharmaceuticals is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the BioCurity Pharmaceuticals deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge